4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-013044
CHAIRMAN & CEO gave up 6,619 shares (to pay taxes)
- CHAIRMAN & CEO acquired 16,561 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Sanj K CHAIRMAN & CEO | 2023-09-01 | Option exercise | +9,992 | 52,566 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2023-09-01 | Shares withheld for taxes | −4,432 | $17.76 | $78,712 | 48,134 | D |
| Patel Sanj K CHAIRMAN & CEO | 2023-09-02 | Option exercise | +6,569 | 54,703 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2023-09-02 | Shares withheld for taxes | −2,187 | $17.76 | $38,841 | 52,516 | D |
| Derivatives | |||||||
| Patel Sanj K CHAIRMAN & CEO | 2023-09-01 | Option exercise · Restricted Share Unit | −9,992 | 29,975 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2023-09-01 | Grant or award · Restricted Share Unit | +25,925 | 25,925 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2023-09-01 | Grant or award · Share Option | +155,500 | 155,500 | D | ||
| Patel Sanj K CHAIRMAN & CEO | 2023-09-02 | Option exercise · Restricted Share Unit | −6,569 | 13,138 | D | ||
Loading xslF345X05/form4-09062023_110936.xml…